ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer.
Mol Ther Oncolytics
; 14: 299-312, 2019 Sep 27.
Article
in En
| MEDLINE
| ID: mdl-31508487
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Mol Ther Oncolytics
Year:
2019
Document type:
Article
Affiliation country:
China
Country of publication:
United States